IGL-200 Successfully Approved by Health Canada
May 15th, 2023 – Era Biology’s Fully Automatic Kinetic Tube Reader (IGL-200), along with its adaptation reagents Fungus (1-3)-β-D-Glucan Detection Kit...
FACIS Successfully Approved by Health Canada
We are glad to announce that the Full-Automatic Chemiluminescence Immunoassay System (FACIS), with its adaptable reagents the Aspergillus Galactomannan ...
Tianjin, China – July 28, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and pioneer of invasive fungal disease diagnostic field since 199...
Genobio Successfully Registered CE-IVDR for Its Instruments
Tianjin, China – October 7, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and...
Era Biology will host global live webinar at 30th June 2022 8:30 (GMT +08:00). The webinar will be in Spanish. The webinar will introduce the last technology for detecting invasive fungal disease. ...
Invasive candidiasis is a frequent life-threatening complication in critically ill patients. Early diagnosis followed by prompt treatment aimed at improving outcome by minimizing unnecessary antifu...